Russia joins the WTO: practical implications for the car industry
In theory, the move by russia to reduce trade restrictions such as import duties would give foreign businesses greater access to the Russian market. However,there are already concerns about how Russia intends to meet the requirements of WTO membership and the impact this will have on domestic sectors. The concern making current headlines relates to the automobile industry and in particular the disposal fee imposed on cars imported into Russia.
As a result of the recent accession to the WTO, Russia has to reduce import customs duties for many categories of pas-senger cars from 25% to 15% by 2019. In addition, from 1 July 2018 Russia will have to discontinue the application of zero or reduced customs duties for car components im-ported by local Semi Knocked Down (‘SKD’) manufacturers under so-called “industrial assembly agreements”. The Russian Ministry of Economy Development had entered into 31 such industrial assembly agreements with car makers and 62 with automotive component manufacturers. Under such agreements, car components intend-ed exclusively for industrial assembly are subject to zero or reduced customs duties. In return, automotive manufactur-ers are to invest in the industry and ensure the gradual substitution of imports with locally produced parts in accord-ance with a localisation schedule agreed with the Ministry.
Pursuant to Russia’s new obligations towards the WTO, the above-mentioned reduced customs duties for SKD car components may only be applied until 1 July 2018. SKD manufacturers which have performed their investment obliga-tions under the industrial assembly agreements are now wondering whether they would be able to keep certain benefits granted under these agreements beyond 1 July 2018. The Ministry has indicated that an alternative scheme would replace the privileges under the industrial assembly agreements…
If you are registered and logged in to the site, click on the link below to read the rest of the DLA Piper briefing. If not, please register or sign in with your details below.
Click on the link above to download this DLA Piper briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
Health Alert — Julia Clare v Australian Community Pharmacy Authority; Dr Reid v Medical Council of NSW; and more
DLA Piper has released the 22 December 2014 issue of its Health Alert, which focuses on judgments, legislation and reports in the health sector.
The European Court of Justice (CJEU) has handed down a landmark judgment concerning the patentability of stem cells in Europe.
Analysis from The Lawyer
Regulators are ramping up the pressure in the aftermath of recession, leaving firms to compete for compliance and restructuring work
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.